Holmusk, a leading behavioral health real-world evidence and data analytics company, announced today that it has been named to the New York Digital Health 100 (DH100), a recognition that highlights the most exciting and innovative digital health startups in the New York region. Digital Health New York (DHNY) publishes the annual list as part of the New York Healthcare Innovation Report, a comprehensive analysis that takes an in-depth look at the data, trends, and people that have propelled New York to become the capital of healthcare innovation.

“We are incredibly honored to be receive this recognition, less than two years after expanding our presence to New York,” said Holmusk Founder and CEO Nawal Roy. “The thriving digital health ecosystem in the city has been vital to our growth and continued success as we build the world’s largest real-world evidence platform for behavioral health, and we look to continuing to contribute to this ecosystem.”

“In 2023, the New York Digital Health 100 includes an incredibly diverse, innovative and forward-thinking set of companies and leaders that are making an impact on the future of healthcare,” said Bunny Ellerin, Co-Founder and CEO, DHNY. “On behalf of the entire New York healthcare ecosystem, we are delighted to spotlight these organizations, support their growth and applaud them for their meaningful contributions to improving healthcare.”

Now in its 4^th year, the DH100 received double the number of applicants compared to 2022. This year’s list represents 35 new companies, counts 12 unicorns among its ranks, has 23 organizations that are led by female CEOs, and 37 of the companies on the list raised $1.6B in 2022.

Holmusk recently closed a $45 million Series B fundraising round, enabling the company to continue its rapid expansion of its flagship offering, NeuroBlu. NeuroBlu is a real-world evidence platform fueled by the behavioral industry’s leading database for clinical data captured during routine care delivery. Drawing from de-identified EHR data from over 1 million patients, NeuroBlu offers uniquely valuable analysis of diagnoses, treatments, behavioral health assessments, symptoms, external stressors, and more.

To download a copy of the New York Healthcare Innovation Report, please click here.

About Holmusk

Holmusk is on a mission to harness real-world data to transform both research and care for behavioral health. Combining the leading behavioral health database with AI-powered analytics and digital solutions designed to address the most pressing challenges in behavioral health, Holmusk is advancing the frontier of evidence generation and fueling innovation.

Holmusk is headquartered in Singapore and New York, with three additional offices around the world. For more information, please visit www.holmusk.com.

About Digital Health New York (DHNY)

Digital Health New York (DHNY) is the premier network of CEOs, entrepreneurs, investors, payers and providers driving New York’s healthcare ecosystem. DHNY works to increase the visibility of New York as a leader in healthcare innovation, showcases the organizations and leaders curating the future of healthcare, and brings people together to share ideas, spark new directions and create success. For more information, visit dhny.co.